Introduction

This is jamma oncology, author interviews, conversations with authors exploring the latest clinical research. I'm happy to be joined by doctor larsbrnebe an, m d, phd, candidate in the department of medical epidemiology and bio statistics, and doctor anna lance, associate professor and specialist in eurology. Both are at the carolinska institute in solna, sweden. And they're here to day to discuss their new publication in jamma onchology, long term effects of five alpharaducta inhibitors on prostate cancer mortality - a large population based cohort study.